Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

55 trials with published results (8%)

Research Maturity

310 completed trials (45% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.0%

28 terminated out of 692 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

11%

73 trials in Phase 3/4

Results Transparency

18%

55 of 310 completed with results

Key Signals

55 with results92% success28 terminated

Data Visualizations

Phase Distribution

439Total
Not Applicable (281)
Early P 1 (7)
P 1 (31)
P 2 (47)
P 3 (25)
P 4 (48)

Trial Status

Completed310
Recruiting140
Unknown115
Active Not Recruiting32
Not Yet Recruiting32
Terminated28

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 310 completed trials

Clinical Trials (692)

Showing 20 of 20 trials
NCT04984226Phase 2RecruitingPrimary

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

NCT06560801Phase 4RecruitingPrimary

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

NCT07115953Not ApplicableRecruiting

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

NCT06410144Not ApplicableRecruitingPrimary

Chronic Kidney Disease-Education (CKD-EDU)

NCT05198674Not ApplicableActive Not Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT06117852Active Not RecruitingPrimary

Chronic Kidney Disease Registry Platform Study

NCT06593392Phase 2Recruiting

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT05557370Phase 4Active Not RecruitingPrimary

Immunogenicity of HPV Vaccine in Transplant Recipients.

NCT06810622Phase 2Recruiting

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

NCT05692388Recruiting

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT05991726CompletedPrimary

A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease

NCT06337838Phase 3RecruitingPrimary

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

NCT05881447RecruitingPrimary

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

NCT07557407Phase 1Not Yet RecruitingPrimary

A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects

NCT05004363Phase 3CompletedPrimary

Lokelma for RAAS Maximisation in CKD & Heart Failure.

NCT05734989Completed

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

NCT05237388Phase 2CompletedPrimary

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

NCT03689569Not ApplicableCompletedPrimary

Effects of Prebiotic Supplementation and Exercise on Inflammatory Markers, Vascular Function and Cognition in CKD

NCT04626167Early Phase 1RecruitingPrimary

Concomitant Renal and Urinary Bladder Allograft Transplantation

NCT07547878Phase 4Active Not RecruitingPrimary

Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)

Scroll to load more

Research Network

Activity Timeline